WallStSmart

DaVita HealthCare Partners Inc (DVA)vsNational HealthCare Corporation (NHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 799% more annual revenue ($14.01B vs $1.56B). NHC leads profitability with a 9.0% profit margin vs 6.0%. DVA appears more attractively valued with a PEG of 0.45. DVA earns a higher WallStSmart Score of 70/100 (B).

DVA

Strong Buy

70

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22

NHC

Buy

61

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 5.3Quality: 9.0
Piotroski: 5/9Altman Z: 3.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DVAOvervalued (-13.0%)

Margin of Safety

-13.0%

Fair Value

$127.66

Current Price

$181.55

$53.89 premium

UndervaluedFair: $127.66Overvalued
NHCSignificantly Overvalued (-65.7%)

Margin of Safety

-65.7%

Fair Value

$101.60

Current Price

$224.47

$122.87 premium

UndervaluedFair: $101.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DVA5 strengths · Avg: 9.6/10
PEG RatioValuation
0.4510/10

Growing faster than its price suggests

Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

EPS GrowthGrowth
55.8%10/10

Earnings expanding 55.8% YoY

Debt/EquityHealth
-14.0910/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

NHC4 strengths · Avg: 9.5/10
EPS GrowthGrowth
67.1%10/10

Earnings expanding 67.1% YoY

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.7010/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Areas to Watch

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

NHC0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : DVA

The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.

Bull Case : NHC

The strongest argument for NHC centers on EPS Growth, Debt/Equity, Altman Z-Score. PEG of 0.82 suggests the stock is reasonably priced for its growth.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Bear Case : NHC

No major red flags identified for NHC, but monitor valuation.

Key Dynamics to Monitor

DVA carries more volatility with a beta of 0.83 — expect wider price swings.

NHC is growing revenue faster at 8.8% — sustainability is the question.

DVA generates stronger free cash flow (320M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DVA scores higher overall (70/100 vs 61/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

National HealthCare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, home health programs, and a behavioral health hospital. The company is headquartered in Murfreesboro, Tennessee.

Want to dig deeper into these stocks?